Press releases

GSK Partners with Save the Children to Address Mental Health Concerns of Children Affected by Cat Lake Crisis in Northern Ontario

New program will use art-based activities as an outlet for Indigenous children to deal with distress they have endured.

Read more - GSK Partners with Save the Children to Address Mental Health Concerns of Children Affected by Cat Lake Crisis in Northern Ontario Read more

Two new options for self-administration of NUCALA now approved in Canada, making it the first anti-IL5 biologic to offer patients with severe eosinophilic asthma a choice of how and where to receive treatment

Read more - Two new options for self-administration of NUCALA now approved in Canada, making it the first anti-IL5 biologic to offer patients with severe eosinophilic asthma a choice of how and where to receive treatment Read more

Many Canadian Adults Acknowledge the Importance of Immunization Yet Are Not Getting Vaccinated

Read more - Many Canadian Adults Acknowledge the Importance of Immunization Yet Are Not Getting Vaccinated Read more

Local employee selected for charity mountain climb

Read more - Local employee selected for charity mountain climb Read more

New Target for HIV Immune Therapy and Cure to be Explored by Trans-Atlantic Industry-Academia Collaboration

Read more - New Target for HIV Immune Therapy and Cure to be Explored by Trans-Atlantic Industry-Academia Collaboration Read more

GSK statement on vaccine shortages

Read more - GSK statement on vaccine shortages Read more

GSK’s Mississauga manufacturing operations undergoes $36 M modernization; Site to produce leading topical pain reliever, VOLTAREN

Read more - GSK’s Mississauga manufacturing operations undergoes $36 M modernization; Site to produce leading topical pain reliever, VOLTAREN Read more

National Advisory Committee on Immunization (NACI) recommends SHINGRIX for the prevention of shingles for adults aged 50 and up

Read more - National Advisory Committee on Immunization (NACI) recommends SHINGRIX for the prevention of shingles for adults aged 50 and up Read more

GSK and NEOMED call for proposals for innovative early stage human therapeutic projects in Quebec

Read more - GSK and NEOMED call for proposals for innovative early stage human therapeutic projects in Quebec Read more

Quebec’s Committee on Immunization (CIQ) recommends preferential use of SHINGRIX for the prevention of shingles in adults aged 50 and up

Read more - Quebec’s Committee on Immunization (CIQ) recommends preferential use of SHINGRIX for the prevention of shingles in adults aged 50 and up Read more